Cost-utility of attachment-based compassion therapy (ABCT) for fibromyalgia compared to relaxation: a pilot randomized controlled trial
Authors
D’Amico, FrancescoFeliu-Soler, Albert
Montero-Marín, Jesús
Peñarrubía-María, María T.
Navarro-Gil, Mayte
Van Gordon, William
García-Campayo, Javier
Luciano, Juan V.
Affiliation
London School of Economics and Political ScienceInstitut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain
Parc Sanitari Sant Joan de Déu, 08830 St. Boi de Llobregat, Spain
University of Barcelona
University of Oxford
PHC Bartomeu Fabrés Anglada, DAP Baix Llobregat Litoral, Unitat Docent Costa de Ponent, Institut Català de la Salut, 08850 Gavà, Spain
Centre for Biomedical Research in Epidemiology and Public Health, CIBERESP, 28029 Madrid, Spain
Miguel Servet Hospital, Aragon Institute of Health Sciences (I+CS), 50009 Zaragoza, Spain
Primary Care Prevention and Health Promotion Research Network, RedIAPP, 28029 Madrid, Spain
Issue Date
2020-03-07
Metadata
Show full item recordAbstract
A recent study has supported the efficacy of Attachment-Based Compassion Therapy (ABCT) compared to relaxation (REL) for the management of fibromyalgia (FM). The main objective of this paper is to examine the cost-utility of ABCT compared to REL in terms of effects on quality-adjusted life years (QALYs) as well as healthcare costs. Forty-two Spanish patients with FM received 8 weekly group sessions of ABCT or REL. Data collection took place at pre- and 3-month follow-up. Cost-utility of the two treatment groups (ABCT vs. REL) was compared by examining treatment outcomes in terms of QALYs (obtained with the EQ-5D-3L) and healthcare costs (data about service use obtained with the Client Service Receipt Inventory). Data analyses were computed from a completers, ITT, and per protocol approach. Data analysis from the healthcare perspective revealed that those patients receiving ABCT exhibited larger improvements in quality of life than those doing relaxation, while being less costly 3 months after their 8-week treatment program had ended (completers: incremental cost M, 95% CI = €−194.1 (−450.3 to 356.1); incremental effect M, 95% CI = 0.023 QALYs (0.010 to 0.141)). Results were similar using an ITT approach (incremental cost M, 95% CI = €−256.3 (−447.4 to −65.3); incremental effect M, 95% CI = 0.021 QALYs (0.009 to 0.033)). A similar pattern of results were obtained from the per protocol approach. This RCT has contributed to the evidence base of compassion-based interventions and provided useful information about the cost-utility of ABCT for FM patients when compared to relaxation. However, the small sample size and short follow-up period limited the generalizability of the findingsCitation
D’Amico, F., Feliu-Soler, A., Montero-Marín, J., Peñarrubía-María, M.T., Navarro-Gil, M., Van Gordon, W., García-Campayo, J. and Luciano, J.V., (2020). ‘Cost-utility of attachment-based compassion therapy (ABCT) for fibromyalgia compared to relaxation: a pilot randomized controlled trial’. Journal of Clinical Medicine, 9(3), pp. 1-14.Publisher
MDPI AGJournal
Journal of Clinical MedicineDOI
10.3390/jcm9030726Additional Links
https://www.mdpi.com/2077-0383/9/3/726Type
ArticleLanguage
enEISSN
2077-0383ae974a485f413a2113503eed53cd6c53
10.3390/jcm9030726
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons